New Treatment for Keratoconus: Corneal Collagen Cross-linking

For individuals struggling with keratoconus, a progressive eye disease that thins the cornea and causes vision distortion, a new breakthrough treatment has emerged. Corneal collagen cross-linking (CXL) is a minimally invasive procedure that strengthens the cornea and halts further progression of the disease.

Dr. Dolan from 2020 Vision in Rochester Hills, MI is among the leading practitioners of this new treatment across the state, and is at the forefront of the revolutionary new approach.

With CXL, doctors apply riboflavin eye drops to the affected eye before administering ultraviolet light. This causes a natural cross-linking process to occur in the cornea, which strengthens it and helps halt the degenerative process.

The procedure takes less than an hour and can be done on an outpatient basis. The earlier the treatment is performed, the more effective it is. CXL has been shown to stabilize the cornea and prevent the need for further interventions such as transplants or corrective lenses.

While keratoconus was once, in some cases, a potential path to blindness, the advent of fast and effective CXL treatments has changed the playing field entirely. As opposed to traditional treatments for keratoconus, which often relied on corrective lenses or transplants to address the issue, CXL provides a more holistic and lasting solution.

If you suspect you may be struggling with keratoconus, don’t hesitate to reach out to Dr. Dolan of 2020 Vision in Rochester Hills, MI for a consultation. Early intervention could make a significant difference in the progression of the disease and the eventual outcome of your vision. So call today at 248 375 0040 to schedule your appointment!